patent ductus defect of CHD tell me every single information of this topic like definition , etiology, symptoms , pathophsiology, digonosis and treatment and also other information

Reading File
Finding Sources
Finding Sources
Searching PubMed

"patent ductus arteriosus"[MeSH Terms]

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Loading Image
I now have all the comprehensive information needed. Let me compile the complete, detailed answer:

Patent Ductus Arteriosus (PDA) - Complete Guide


1. Definition

Patent Ductus Arteriosus (PDA) is a congenital heart defect in which the ductus arteriosus - a normal fetal vascular channel connecting the main pulmonary artery (or left pulmonary artery) to the upper descending thoracic aorta, just distal to the origin of the left subclavian artery - fails to close after birth.
  • In fetal life, the ductus is functionally essential, carrying approximately 60% of combined ventricular output from the pulmonary artery to the aorta (bypassing the fluid-filled, non-functional lungs).
  • After birth, it should close functionally within 10-15 hours and anatomically (forming the ligamentum arteriosum) within the first few months.
  • When it fails to close, blood shunts from the high-pressure aorta into the lower-pressure pulmonary artery (left-to-right shunt), causing pulmonary overcirculation and left heart volume overload.
PDA accounts for approximately 7% of all congenital heart lesions, with about 90% of these being isolated defects.
- Robbins & Kumar Basic Pathology, Schwartz's Principles of Surgery 11th Ed.

2. Anatomy

PDA Anatomy - showing connection between aorta and pulmonary artery
Anatomy of a patent ductus arteriosus. The ductus connects the pulmonary trunk (PT) to the aorta (Ao), just distal to the left subclavian artery (SCA). Ao = aorta; BCA = brachiocephalic artery; CCA = common carotid artery; LPA = left pulmonary artery; PDA = patent ductus arteriosus; PT = pulmonary trunk; RPA = right pulmonary artery; SCA = subclavian artery. (Goldman-Cecil Medicine)
  • The ductus is derived from the 6th aortic arch (left side).
  • In the neonate, its length ranges from 2 to 8 mm and diameter from 4 to 12 mm.
  • Normal closure leaves a fibrous remnant called the ligamentum arteriosum.

3. Etiology & Risk Factors

Incidence

  • Approximately 1 in every 2000 births in term infants.
  • Dramatically increases with prematurity - present in up to 75% of infants born at 28-30 weeks gestation.
  • Female predominance: 2:1 female-to-male ratio.

Causes & Risk Factors

CategoryDetails
PrematurityMost important risk factor. Virtually ALL preterm neonates ≤28 weeks with birth weight <1750 g have a PDA in the first 24 hours
HypoxiaRespiratory distress syndrome (RDS), surfactant deficiency, high-altitude residence - all reduce oxygen tension, which is the main stimulus for ductal closure
Maternal RubellaOne of the classic teratogenic associations; rubella in early pregnancy strongly associated with PDA
Failure of TGF-β inductionTGF-β normally triggers post-natal ductal involution; its absence may cause persistent patency
Chromosomal anomaliesTrisomy 21 (Down syndrome), trisomy 18, etc.
Associated CHDsCoarctation of the aorta, Transposition of the Great Arteries (TGA), pulmonary stenosis/atresia - large pressure differences between aorta and pulmonary artery prevent normal constriction
PharmacologicProstaglandin infusion (used therapeutically to keep ductus open in duct-dependent lesions)
- The Developing Human (Clinically Oriented Embryology), Schwartz's Principles of Surgery

4. Normal Physiology of Ductal Closure

Understanding normal closure explains why PDA occurs:
  1. Fetal state: Locally produced prostaglandin E2 (PGE2) and prostaglandin I2 (PGI2) maintain active muscular relaxation of the ductal wall, keeping it widely patent. Placenta is also a key source of these prostaglandins.
  2. At birth:
    • Increased pulmonary blood flow metabolizes PGE2 and PGI2.
    • Removal of the placenta eliminates a major prostaglandin source.
    • Release of histamines, catecholamines, bradykinin, and acetylcholine promote ductal contraction.
    • Rising arterial oxygen tension is the primary stimulus for smooth muscle contraction - ductal closure begins within 10-15 hours.
  3. Anatomic closure by fibrosis occurs over subsequent weeks to months, producing the ligamentum arteriosum.
- Schwartz's Principles of Surgery 11th Ed.

5. Pathophysiology

The hemodynamic consequences depend entirely on the size of the ductus and the pressure/resistance ratio between the pulmonary and systemic circulations.

Left-to-Right Shunt (the usual pattern)

Since aortic pressure exceeds pulmonary artery pressure throughout the cardiac cycle (both systole AND diastole), blood flows continuously from the aorta into the pulmonary artery. This results in:
  • Pulmonary overcirculation: increased pulmonary blood flow returning to the left atrium.
  • Left atrial and left ventricular volume overload with dilation.
  • Elevated pulmonary artery pressure - if large/unrestrictive shunt.
  • Right ventricular strain from augmented afterload.
  • Increased sympathetic discharge → tachycardia, tachypnea, ventricular hypertrophy.
  • Lowered aortic diastolic pressure (blood escaping into the pulmonary artery in diastole) → bounding/waterhammer pulse and widened pulse pressure.
  • Coronary and splanchnic steal - reduced diastolic aortic pressure compromises coronary perfusion and gut perfusion, particularly dangerous in premature infants.

Small PDA

  • Continuous flow throughout the cardiac cycle.
  • No significant left heart dilation, no pulmonary hypertension, no symptoms.
  • BUT - carries a risk of infectious endarteritis of ~0.45% per year after the second decade (turbulent flow damages the endothelium of the pulmonary artery opposite the ductus).

Moderate/Large PDA

  • Left atrial and ventricular dilation develops.
  • Pulmonary hypertension of variable degree.
  • Symptoms appear progressively in the 2nd-3rd decades (dyspnea, palpitations, exercise intolerance).
  • Mortality rises to 3-4% per year by the 4th decade; two-thirds of patients die by age 60 if untreated.

Eisenmenger Syndrome (~5% of isolated PDA cases)

  • Sustained pulmonary hypertension causes progressive pulmonary vascular disease.
  • When pulmonary vascular resistance equals or exceeds systemic resistance, the shunt reverses to right-to-left.
  • Deoxygenated blood enters the descending aorta (DISTAL to the left subclavian artery) → differential cyanosis (lower extremities more cyanosed and clubbed than upper extremities and right hand).
- Goldman-Cecil Medicine, Schwartz's Principles of Surgery

6. Clinical Manifestations & Symptoms

Neonates & Infants (premature)

  • Respiratory distress / failure to wean from ventilator
  • Tachycardia, tachypnea
  • Bounding pulses, hyperdynamic precordium
  • Widened pulse pressure
  • Apnea spells
  • Feeding difficulties, poor weight gain
  • Increased ventilator requirements

Children & Adults (uncorrected)

  • Small PDA: usually asymptomatic; detected as murmur
  • Moderate/Large PDA:
    • Dyspnea on exertion
    • Palpitations
    • Exercise intolerance
    • Recurrent respiratory infections
    • Features of congestive heart failure (pulmonary edema, hepatomegaly)

Differential Cyanosis (Eisenmenger)

  • Cyanosis and clubbing of the toes (lower extremities), while upper extremities and right hand remain normal - this is pathognomonic of Eisenmenger physiology with PDA.

7. Physical Examination Findings

FindingDetails
Continuous "machinery" murmurHeard at the 1st-2nd left intercostal space below the left clavicle (infraclavicular region). Peaks at S2, continues through diastole. It is the hallmark of PDA.
Bounding/waterhammer pulseDue to increased stroke volume and low diastolic BP
Widened pulse pressureFrom aortic diastolic runoff into pulmonary artery
Hyperdynamic precordiumHyperactive apical impulse from LV volume overload
ThrillMay be palpable at the 2nd left intercostal space
Differential cyanosis/clubbingToes > fingers (Eisenmenger physiology)
Note on murmur changes with pulmonary hypertension: As pulmonary pressure rises, the diastolic component of the murmur shortens progressively. With full Eisenmenger physiology, the entire murmur may disappear, replaced by signs of pulmonary hypertension (loud P2, etc.).

8. Investigations & Diagnosis

Chest X-Ray (CXR)

  • Increased pulmonary vascular markings (pulmonary plethora)
  • Cardiomegaly (left-sided enlargement)
  • Dilated ascending aorta and pulmonary artery trunk
  • In older patients: calcification at the site of the PDA
Chest X-ray before and after PDA ligation
Chest X-ray before (left) and after (right) PDA ligation, showing dramatic improvement in pulmonary vascularity. The red star (right image) points to the surgical clip used for ligation. (Schwartz's Principles of Surgery)

Electrocardiogram (ECG)

  • Left ventricular strain pattern
  • Left atrial enlargement (broad, notched P waves)
  • Right ventricular hypertrophy if pulmonary hypertension has developed

Echocardiography (Primary Diagnostic Tool)

  • 2D echo: may directly visualize the ductus (easier in neonates; harder in adults due to limited acoustic window).
  • Color Doppler: detects the characteristic continuous, turbulent flow jet entering the pulmonary artery from the aorta. Sensitivity 96%, specificity 100% for PDA diagnosis.
  • Left atrial and left ventricular dilation (volume overload markers).
  • Suprasternal notch Doppler: holodiastolic flow reversal in the descending aorta (blood flowing antegrade into ductus in diastole).
  • LA:Ao ratio >1.4 suggests significant left-to-right shunt.
Echocardiogram of PDA - color Doppler and CW Doppler
Echocardiographic findings of PDA. LEFT: Parasternal short-axis view showing a color Doppler jet (arrow) entering the pulmonary artery (PA) from the descending aorta (DA) in diastole. RIGHT: CW Doppler showing characteristic high-velocity continuous flow (both diastole and systole) toward the transducer. This "diastole-to-systole" uninterrupted flow is diagnostic of PDA. (Textbook of Clinical Echocardiography)

Cardiac Catheterization

  • Not routinely needed for diagnosis.
  • Indicated when pulmonary hypertension is suspected - to measure pulmonary vascular resistance and assess reversibility (determines if closure is safe).
  • Step-up in oxygen saturation at the pulmonary artery level (compared to RV) confirms left-to-right shunting.
  • Contraindicated in established Eisenmenger syndrome.

CT Angiography / MRI

  • Used when echocardiographic windows are poor.
  • CT angiography can directly visualize the ductus and assess pulmonary vasculature.
- Goldman-Cecil Medicine, Textbook of Clinical Echocardiography, Schwartz's Principles of Surgery

9. Treatment

General Principles

  • The presence of a persistent PDA is itself a sufficient indication for closure (risk of endocarditis, CHF, pulmonary hypertension).
  • Exception: Eisenmenger syndrome - closure is CONTRAINDICATED (would remove the "pop-off valve" for the right ventricle).
  • In duct-dependent congenital lesions (e.g., pulmonary atresia, critical coarctation), the ductus must be kept open with prostaglandin E1 (PGE1) infusion until corrective surgery.

A. Pharmacologic Closure (Premature Infants Only)

Cyclo-oxygenase (COX) inhibitors block prostaglandin synthesis, removing the main vasodilatory stimulus on the ductal smooth muscle.
DrugNotes
Indomethacin (IV)First-line in premature infants. Multiple dosing regimens. Effective but has side effects (renal insufficiency, necrotizing enterocolitis, platelet dysfunction).
Ibuprofen (IV or oral)Comparable efficacy to indomethacin with fewer renal side effects. Ibuprofen may accelerate closure but may not reduce the need for procedural intervention in all cases.
Acetaminophen (paracetamol)Increasingly used as an alternative with fewer GI and renal side effects. Acts via a different mechanism (inhibits prostaglandin peroxidase).
Term infants are generally unresponsive to pharmacologic therapy and require mechanical/procedural closure.
Contraindications to pharmacologic therapy:
  • Necrotizing enterocolitis
  • Renal insufficiency / oliguria
  • Active bleeding (especially intraventricular hemorrhage)
  • Thrombocytopenia
  • Hyperbilirubinemia (indomethacin displaces bilirubin)

B. Transcatheter (Percutaneous) Device Closure

Now the preferred treatment for most children and adults (symptomatic or after infancy).
Devices used:
  • Gianturco coils - for small PDAs (<3 mm). Coil occlusion.
  • Rashkind double-umbrella device - older technique, still used.
  • Amplatzer Duct Occluder (ADO) - most widely used today; delivered via a femoral vein or artery catheter.
  • Piccolo Occluder - for very small/premature infants.
Advantages: Avoids surgery, shorter recovery, excellent results in experienced centers.
Complications: Thromboembolism, incomplete occlusion (residual shunt 0.5-8% depending on device), device embolization, vascular injury, endocarditis, hemorrhage from perforation.
Limitations: Not applicable in very premature/small infants due to vessel access size constraints.

C. Surgical Closure

Indicated when:
  • Transcatheter approach is not feasible (very premature, large ductus with complex anatomy)
  • Failed device closure
  • Associated cardiac defects requiring open surgery
Techniques:
  1. Ligation - single ligature with surgical clip or permanent suture. Approach via left posterior-lateral thoracotomy (3rd or 4th intercostal space), with lung retracted anteriorly.
  2. Division with oversewing - used when the ductus is short and broad (width approaches length). Both ends oversewn between vascular clamps.
  3. Video-Assisted Thoracoscopic Surgery (VATS) - metal clip ligation via thoracoscope. Few advantages over open in most centers.
  4. Median sternotomy - reserved for patients needing simultaneous repair of additional cardiac lesions.
Key anatomic hazard: The recurrent laryngeal nerve loops around the PDA and must be identified and protected to avoid left vocal cord paralysis.
Outcomes:
  • Operative mortality: <1% in uncomplicated cases; up to 8% with severe pulmonary hypertension or calcification.
  • After ligation in infancy/early childhood, cardiac function is typically normal and no special follow-up is required.
- Schwartz's Principles of Surgery, Goldman-Cecil Medicine

10. Complications of Untreated PDA

ComplicationDetails
Congestive Heart FailureLeading cause of death in untreated PDA (30% estimated mortality in isolated untreated PDA)
Pulmonary HypertensionProgressive pulmonary vascular disease
Eisenmenger SyndromeOccurs in ~5% of isolated PDA; shunt reversal, irreversible
Infective Endarteritis~0.45% per year; turbulent jet damages pulmonary artery endothelium; more common with small PDAs
Recurrent Respiratory InfectionsFrom pulmonary congestion
Failure to thriveParticularly in infants
Aneurysm of ductusRare; can occur in older unrepaired patients or as a complication of closure

11. Special Situations

PDA in Premature Infants

  • Near-universal in very premature neonates (≤28 weeks, <1750 g).
  • Manifests as respiratory failure, inability to wean from ventilator, hypotension, metabolic acidosis.
  • Conservative management (fluid restriction, diuretics) may be tried first.
  • Pharmacologic closure with indomethacin or ibuprofen is first-line if no contraindications.
  • Surgical ligation if pharmacologic therapy fails or is contraindicated.

PDA as a Lifesaving Channel (Duct-Dependent Lesions)

In certain complex CHDs, either pulmonary or systemic circulation depends entirely on the ductus:
  • Pulmonary atresia, critical pulmonary stenosis - ductus is the only source of pulmonary blood flow.
  • Hypoplastic left heart syndrome, critical aortic stenosis, critical coarctation - ductus maintains systemic perfusion.
  • These patients require IV prostaglandin E1 (PGE1/alprostadil) infusion to keep the ductus open until surgical/interventional palliation.

PDA in Adults

  • Often discovered incidentally or presents with exertional dyspnea, palpitations.
  • Continuous machinery murmur is the hallmark.
  • Older patients may show calcification of the ductus on chest X-ray.
  • Transcatheter closure is well-established and effective in adults.
  • Eisenmenger physiology must be excluded before proceeding with closure.

12. Classification / Types of PDA

Krichenko classification (by angiographic morphology):
  • Type A (conical) - most common; funnel-shaped, narrow at pulmonary end.
  • Type B (window) - short, broad ductus.
  • Type C (tubular) - uniform caliber, no constriction.
  • Type D (complex) - multiple constrictions.
  • Type E (elongated) - long, tortuous ductus, usually in older patients.

13. Prognosis

  • Small PDA that is closed early: excellent prognosis, normal life expectancy.
  • Untreated moderate/large PDA: 3-4% annual mortality by the 4th decade; two-thirds of patients die by age 60.
  • Estimated overall death rate for untreated isolated PDA: ~30% (primarily CHF and respiratory infections).
  • Eisenmenger physiology: poor prognosis, median survival into 30s-40s; closure contraindicated.
  • Post-closure in Eisenmenger: mortality may worsen acutely (right ventricular decompensation without the pulmonary "pop-off").

14. Key Summary Table

FeatureDetail
Embryologic origin6th aortic arch
Normal closureFunctional: 10-15 hrs; Anatomic: weeks-months
Trigger for closureRising O2 tension (primary), fall in prostaglandins
Incidence1:2000 births (term); up to 75% at 28-30 weeks
Sex ratioF:M = 2:1
Classic murmurContinuous "machinery" murmur, left infraclavicular
Shunt directionL→R (aorta to pulmonary artery) initially
Best diagnostic testColor Doppler echocardiography (96% sensitivity, 100% specificity)
Pharmacologic closureIndomethacin / Ibuprofen / Paracetamol (premature infants only)
Preferred closureTranscatheter device (Amplatzer, coil)
SurgeryLigation or division; left thoracotomy
Key complicationCHF, pulmonary HTN, Eisenmenger, endarteritis
Differential cyanosisToes > fingers = pathognomonic of Eisenmenger + PDA
Eisenmenger closureCONTRAINDICATED

Sources:
This is a shared conversation. Sign in to Orris to start your own chat.